Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Encodia Inc. in September, 2018 for $222,959.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM130185-01 | Phase I | 222,959 | September 13, 2018 | |||||||
A SBIR Phase I contract was awarded to Encodia Inc. in September, 2019 for $224,579.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM134752-01 | Phase I | 224,579 | September 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Encodia Inc. in September, 2020 for $749,718.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM130185-02 | Phase II | 749,718 | September 15, 2020 | |||||||
A SBIR Phase II contract was awarded to Encodia Inc. in September, 2018 for $1,450,120.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA203629-02 | Phase II | 1,450,120 | September 20, 2018 | |||||||
A SBIR Phase II contract was awarded to Encodia Inc. in February, 2020 for $736,945.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM123836-02A1 | Phase II | 736,945 | February 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Encodia Inc. in May, 2021 for $256,182.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM142375-01 | Phase I | 256,182 | May 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Encodia Inc. in September, 2017 for $223,600.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM123836-01 | Phase I | 223,600 | September 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Encodia Inc. in September, 2016 for $211,400.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA203629-01 | Phase I | 211,400 | September 5, 2016 |